Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on August 24, 2016, to report a significant corporate event under Item 8.01 Other Events. The company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused on a specific event rather than periodic financial performance.
Material Changes
The material change reported is the issuance of a press release on August 24, 2016, announcing a new patent application. The application discloses a method for regenerating failing ovaries using a specific type of stem cell extracted from a patient's own tissues.
Guidance, Outlook, and Risks
The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of the filing date. Management warns that actual results could differ materially from anticipated outcomes due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. The Company explicitly states it assumes no duty or obligation to update or revise these forward-looking statements.
Investor Verification Checklist
- Verify the status and scope of the new patent application regarding ovarian regeneration via stem cells.
- Review the full text of the press release attached as Exhibit 99.1 for specific technical details.
- Consult the Form 10-K for the year ended December 31, 2015, to understand the risk factors referenced in the forward-looking statement disclaimer.
- Confirm the company's current financial position through separate periodic filings, as this 8-K contains no financial data.